|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.357 USD | -1.10% |
|
-2.25% | -53.80% |
| 06-28 | Atara Biotherapeutics, Inc.(NasdaqGS:ATRA) dropped from Russell 3000E Value Benchmark | CI |
| 06-28 | Atara Biotherapeutics, Inc.(NasdaqGS:ATRA) dropped from Russell Microcap Value Benchmark Index | CI |
| Market Cap | 76.14M 65.86M 61.5M 56.42M 106M 7.25B 108M 722M 283M 3.63B 286M 280M 12.01B | P/E 2026 * |
-8.74x | P/E 2027 * | 7.36x |
|---|---|---|---|---|---|
| Enterprise Value | 76.14M 65.86M 61.5M 56.42M 106M 7.25B 108M 722M 283M 3.63B 286M 280M 12.01B | EV / Sales 2026 * |
36.2x | EV / Sales 2027 * | 1.69x |
| Free-Float |
83.08% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.10% | ||
| 1 week | -2.25% | ||
| Current month | -0.27% | ||
| 1 month | -14.37% | ||
| 3 months | -4.82% | ||
| 6 months | +73.03% | ||
| Current year | -53.80% |
| 1 week | 8.09 |  | 9.11 |
| 1 month | 7.39 | | 9.61 |
| Current year | 3.92 | | 19.14 |
| 1 year | 3.92 | | 19.14 |
| 3 years | 3.92 | | 53.75 |
| 5 years | 3.92 | | 501 |
| 10 years | 3.92 | | 1,361.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anhco Nguyen
CEO | Chief Executive Officer | 53 | 2024-09-08 |
Kevin Sarney
DFI | Director of Finance/CFO | 61 | 2026-06-25 |
Jason Awe
IRC | Investor Relations Contact | - | 2023-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Fust
BRD | Director/Board Member | 61 | 2014-02-28 |
William Heiden
BRD | Director/Board Member | 66 | 2015-11-22 |
Anhco Nguyen
BRD | Director/Board Member | 53 | 2024-09-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/22/26 | Redmile Group LLC
| Fiscal year | Company | 390,482 | 4.3338% | |
| 1/12/26 | Panacea Venture
| Sell | Company | 80,554 | 1.1172% | |
| 11/28/25 | Panacea Venture
| Fiscal year | Company | 97,475 | 1.3879% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.10% | -2.25% | -19.02% | -84.67% | 76.14M | |
| +4.21% | +25.62% | +77.96% | +111.62% | 68.12B | |
| +0.60% | +6.26% | +38.72% | +67.92% | 55.18B | |
| +1.66% | +35.37% | +18.05% | +486.58% | 28.63B | |
| +0.57% | +19.05% | +57.08% | +5.18% | 23.99B | |
| +0.36% | +1.76% | -14.09% | -10.99% | 23.53B | |
| -0.35% | +7.91% | +46.74% | -22.61% | 18.45B | |
| -2.04% | +9.24% | +31.14% | +650.71% | 16.44B | |
| +7.26% | +25.47% | +221.03% | +383.67% | 15.83B | |
| -1.34% | -3.12% | +42.58% | +152.20% | 13.4B | |
| Average | +0.97% | +10.27% | +50.02% | +173.96% | 26.36B | |
| Weighted average by Cap. | +1.68% | +11.64% | +54.79% | +165.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.11M 1.82M 1.7M 1.56M 2.93M 200M 2.98M 19.95M 7.83M 100M 7.91M 7.73M 332M | 45.08M 38.99M 36.41M 33.4M 62.82M 4.29B 63.82M 427M 168M 2.15B 169M 166M 7.11B |
| Net income | -13.19M -11.41M -10.65M -9.77M -18.38M -1.25B -18.67M -125M -49.05M -629M -49.51M -48.43M -2.08B | 16.53M 14.3M 13.36M 12.25M 23.05M 1.57B 23.41M 157M 61.51M 789M 62.09M 60.73M 2.61B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | US$8.357 | -1.10% | 6,201 |
| 26-08-07 | US$8.450 | +2.42% | 23,213 |
| 26-08-06 | US$8.250 | -3.40% | 22,856 |
| 26-08-05 | US$8.540 | -2.62% | 32,523 |
| 26-08-04 | US$8.770 | +2.57% | 42,283 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATRA Stock
Select your edition
All financial news and data tailored to specific country editions
